Optimal Recovery From Psychosis: Clozapine/Engagement/Community

Dates and Times

Start: 4/14/2026 11:00 AM
End: 4/14/2026 12:00 PM

Objectives

1.  Understand the population that we are dealing with. This is the entire psychosis spectrum across diagnostic boundaries. The resistant psychosis population and those patients with suicidality have special relevance.

2. Understand the problem that we have dramatically poor outcomes in Schizophrenia spectrum disorders, with less than 15 % in meaningful recovery, and hundreds of thousands incarcerated and homeless. In this population we have a dramatic under use of the most effective antipsychotic Clozapine. If you fail 1 antipsychotic it is time to use clozapine.

3. Develop an understanding about how to use EASE and that using the EASE approach results in meaningful recovery in most patients.

4. Learn how to effectively mitigate side effects of clozapine and optimize it's safety and efficacy.

Speakers

Location

HSC, Level 10, Conf. Rooms 021, 085A/B
Stony Brook University
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Psychology Continuing Education Accreditation

Stony Brook University Department of Psychiatry & Behavioral Health is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0241.